The BARDA Accelerator Network Hub
for Medical Devices and Diagnostics
LoBio is reimagining the future of blood testing with the P1, a device that allows anyone to self-collect laboratory quality plasma from the comfort of their home. With the P1, time, distance, and money will no longer be barriers that prevent people from getting the essential tests they need.
Adaptyx Biosciences is developing wearable sensors that continuously measure panels of molecules in real time
RUA is developing groundbreaking technology through the use of breath analysis with gas chromatography (GC), enabling diagnostic testing for various highly prevalent and lethal diseases, all through a single test.
Latde Diagnostics is developing tools to rapidly guide antibiotic treatment, starting with urinary tract infections (UTIs). Our instrument-free diagnostic test will save and improve lives, promote antibiotic stewardship and help combat health inequity.
We build solid-state third-generation sequencers that are more powerful and accessible to democratize the future of sequencing.
Checktor Biosciences enables guided antibiotic treatments at the point-of-care within a single visit by leveraging their patented CRISPR biosensor.
We are a home-health diagnostics start-up based on Harvard technology. Our mission is to disrupt blood testing with a test simple enough to use at home, as accurate as lab-grade results and as familiar as the widely-adopted glucometer.
Hikari provides cutting-edge drug dosing and monitoring systems, consisting of a drug carrier paired with a wearable device. By providing a safer, more convenient drug product, we lower the administrative burden associated with therapeutically valuable antimicrobial drugs.